I was six years old when open heart surgery saved my brother’s life. It was the first of many times when I thought about becoming a doctor, so that I, too, could save someone’s life. For more than 26 years, I’ve had that opportunity. I’ve treated more than 5,000 patients who’ve had prostate cancer and are now thriving after having their prostate gland removed through a procedure known as radical prostatectomy.
I came to NYU Langone in 1993, because I had a tremendous opportunity to build a world-class urology department here. Since then, our department has defined state-of-the-art care by improving outcomes for radical prostatectomy. For example, we now use a technique that spares the nerves, preserving function as much as possible.
We have also pioneered the use of MRI to diagnose and pinpoint the precise location of prostate cancer. More than 90 percent of patients who’ve needed surgery to remove the prostate at NYU Langone have reported long-term satisfaction with the outcomes.
We are at the forefront of research into prostate cancer, using image-guided diagnostic techniques, such as MRI, to help us determine the best treatment—whether it’s surveillance of slow-growing cancer, the need for complete removal of the prostate, or destroying one malignant area without using surgery.
It's the connection we make with patients and their families that humanizes medicine in this age of technology. For this reason, I take the time to listen to my patients and guide them through treatment, every step of the way.
Conditions and Treatments
- Professor, Department of Urology
- Professor, Department of Biochemistry and Molecular Pharmacology
- Urology Chief
- Martin Spatz Chair Dept of Urology
- American Board of Urology - Urology, 1987
Education and Training
- Residency, Johns Hopkins Hospital, 1985
- Residency, Johns Hopkins Hospital, 1981
- MD from Johns Hopkins University, 1979
Locations and Appointments
- Cigna EPO/POS
- Cigna PPO
- Empire Blue Cross Blue Shield Child Health
- Empire Blue Cross Blue Shield EPO
- Empire Blue Cross Blue Shield HMO
- Empire Blue Cross Blue Shield Indemnity
- Empire Blue Cross Blue Shield POS
- Empire Blue Cross Blue Shield PPO
- Empire Blue Cross Blue Shield Pathways, Enhanced
- HealthSmart (WTC)
- MagnaCare PPO
- MultiPlan/PHCS PPO
- Oxford Exchange
- Oxford Freedom
- Oxford Liberty
- UnitedHealthcare EPO
- UnitedHealthcare HMO
- UnitedHealthcare POS
- UnitedHealthcare PPO
- UnitedHealthcare Top Tier
“We have worked to improve the technique for removing the prostate, preserving as many nerves as possible.”Herbert Lepor, MD Urologist
The Challenge for Urologists Is to Screen, Detect, and Treat Prostate Cancer "Smarter": Will Ablative Technology Result in Smarter Treatment?
European urology. 2016 Jan. ?-?
Predictive Value of Negative 3T Multiparametric Prostate MRI on 12 Core Biopsy Results
Wysock, James S; Mendhiratta, Neil; Zattoni, Fabio; Meng, Xiaosong; Bjurlin, Marc; Huang, William C; Lepor, Herbert; Rosenkrantz, Andrew B; Taneja, Samir S
BJU international. 2016 Jan. ?-?
Natural History of Pathologically Benign Multi-parametric MRI Cancer Suspicious Regions Following MRI-Ultrasound Fusion-targeted Biopsy
Bryk, Darren J; Llukani, Elton; Huang, William C; Lepor, Herbert
Journal of urology. 2015 May. 1234-1240